Delivery Order 36C24822D0086-36C24824N0736
- Not listed
- Karius, Inc. has been awarded a $22,000 delivery order by Veterans Integrated Service Network 17 (VISN 17), a civilian agency within the Department of Veterans Affairs, for its Karius Next Generation Sequencing Test. The contract, issued on April 1, 2026, with an ultimate completion date of March 31, 2027, represents a firm fixed-price delivery order without a set-aside designation. The place of performance is located in Redwood City, California, where Karius, Inc. maintains its headquarters....
- The U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 8 has awarded Karius, Inc. a firm-fixed-price delivery order contract for its Karius Next Generation Sequencing (NGS) diagnostic test. The contract has a ceiling value of $60,000 and a performance period from August 1, 2023 to July 31, 2024. This award is part of a larger $600,000 Indefinite Delivery Contract (IDC) that Karius holds with the VA VHA, which has an ultimate completion date of July 31, 2027. The...
- On April 1, 2025, the Department of Veterans Affairs, Veterans Integrated Service Network 17, awarded a delivery order valued at $22,000 to Karius, Inc. under contract 36C25725D0031 (Order #36C25725N0219). This firm fixed-price delivery order, with an ultimate completion date of March 31, 2026, represents performance at the contractor's location in Harlingen, Texas. The award was issued without set-aside designation and leverages Karius, Inc.'s specialized capabilities in next-generation...
- This contract was awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in diagnostic testing for infectious diseases. The contract, valued at $80,000.00, is for the provision of molecular diagnostic testing services using Karius' liquid biopsy technology to rapidly screen patients for various pathogens. The testing services will be delivered within 3-4 days of specimen receipt. This is a firm fixed-price purchase order...
- This is a $44,000 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing (NGS) technologies focused on infectious disease detection. The contract is for the procurement of molecular diagnostic testing services, with an ultimate completion date of September 14, 2026. Karius, Inc. has previously held Indefinite Delivery...
- This is a firm fixed price purchase order awarded by the Defense Health Agency (DHA) to Karius, Inc. for quantitative next-generation sequencing testing services. The $240,000 contract supports DHA programs through September 2023 and leverages Karius' expertise in genomic sequencing to rapidly screen patients for various pathogens. This is a sole source award, as Karius is the only commercial laboratory capable of providing the requested cell-free DNA testing from plasma samples with 24-72...
- The Department of the Navy Bureau of Medicine and Surgery awarded a $140,000 firm fixed price purchase order to Karius, Inc. for the provision of 70 quantitative next generation sequencing tests. This award is not associated with a larger contract vehicle and does not have a set-aside designation. Karius, Inc. is a life sciences company focused on diagnostic testing for infectious diseases. The purchase order supports Department of Defense programs through September 2027 and leverages Karius'...
- The Defense Health Agency (DOD) awarded a $250,000 firm fixed price purchase order to Karius, Inc., doing business as Karius Inc., located in San Diego, California. The contract is for Quantitative Next-Gen Sequencing Testing Services and has a period of performance from October 1, 2022 through September 30, 2023. Karius provides genomic sequencing and bioinformatics analysis services to identify pathogens and monitor antimicrobial resistance. No applicable subcontractors were identified in...
- This federal contract award is for a Quantitative Next-Gen Sequencing Test to be provided to the Naval Medical Center San Diego Lab Department. The $240,000.00 firm fixed-price purchase order was awarded to Karius, Inc., a life sciences company specializing in advanced molecular diagnostic testing and next-generation sequencing technologies. The contract, which does not have a set-aside designation, has an ultimate completion date of September 30, 2027 and was awarded on October 1, 2023....
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 awarded a $22,000 firm fixed price delivery order contract to Karius, Inc., doing business as Karius, to provide Karius Laboratory Tests for the Orlando VA Medical Center. Karius will perform laboratory testing services for the Orlando VAMC from its location in Redwood City, California under the one-year contract running from August 2022 through July 2023. The Veterans Health Administration...
- 36C24822D0086Indefinite Delivery Contract
- 36C24822D0086-36C24824N0736Delivery Order
The Department of Veterans Affairs, through Veterans Integrated Service Network 8, awarded a delivery order valued at $46,000 to Karius, Inc. for the provision of next-generation sequencing (NGS) testing services. This delivery order, effective through July 31, 2025, represents the third year of testing delivery under a firm fixed-price contract structure with no set-aside designation. Karius, Inc., headquartered in Redwood City, California, is a specialized life sciences company focused on advanced molecular diagnostic testing and genomic sequencing for infectious disease detection. The contractor will perform services at its Redwood City facility. This delivery order is issued against one of two larger Indefinite Delivery Contracts (IDCs) valued at $600,000 each that the VA has established with Karius, Inc. through Veterans Integrated Service Network 8 and Network Contracting Office 17. Under these IDCs, which remain effective through July 31, 2027, the VA purchases Karius' next-generation sequencing tests at $2,000 per test, with Karius identified as the sole responsible source. These contracts enable the VA to leverage Karius' specialized capabilities in high-complexity genomic testing to support comprehensive diagnostic services and infectious disease identification for veterans nationwide, with particular focus on rapid pathogen detection and antimicrobial resistance monitoring.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Funding Only Action | ($74k) | 11/25/25 | |
| Not listed | Not listed | $120.0k | 7/31/24 |